Who can get a prescription for Ozempic in the EU?

Ozempic (semaglutide) is a prescription-only GLP-1 receptor agonist approved in the EU for adults with type 2 diabetes under defined clinical criteria. In this episode, we explain eligibility, assessment requirements, and when prescriptions may be declined.

In this episode, we cover:

• What Ozempic is (a GLP-1 receptor agonist for type 2 diabetes)

• EU-approved indication: adults with insufficient glycaemic control

• HbA1c thresholds and prior treatment requirements

• Use alongside diet, exercise, and other glucose-lowering medicines

• Differences between Ozempic and weight-specific semaglutide brands

• Contraindications: type 1 diabetes, certain thyroid conditions

• Required monitoring: HbA1c, kidney function, side effects ...